TCSG selected for National Science Foundation grants

May 22, 2023 | The Technical College System of Georgia (TCSG) is proud to announce its selection as the workforce partner for three U.S. National Science Foundation (NSF) Regional Innovation Engine grants in Georgia. These grants represent significant milestones in advancing cutting-edge research and innovation in key sectors, and TCSG is honored to be at the forefront of these transformative initiatives.

Technical College System of Georgia (TCSG) logo

“These NSF Regional Innovation Engine grants underscore the Technical College System of Georgia’s commitment to driving innovation and economic growth within the state,” said TCSG Commissioner, Greg Dozier. “As the chosen workforce partner for these transformative projects, we are excited to play a vital role in shaping the future of agriculture, healthcare, and cybersecurity. TCSG’s extensive network of colleges is uniquely positioned to deliver industry-relevant training and prepare a skilled workforce that will contribute to the success of these initiatives.”

The first grant, awarded to support the  Next Generation Agriculture project , marks a groundbreaking collaboration under the academic leadership of the University of Georgia and Fort Valley State University. This joint effort aims to propel Georgia farmers towards the “Ag 4.0” revolution. By leveraging the latest advancements in technology and data analytics, the project seeks to revolutionize agricultural practices and equip farmers with the tools they need to thrive in the modern era. By leveraging its extensive network of technical colleges and industry connections, TCSG will provide targeted workforce training and support services tailored to the specific needs of farmers in the region. Through this collaboration, TCSG will contribute to the overall success of NextGA by equipping farmers with the skills and knowledge required to thrive in the evolving landscape of agriculture.

The second grant, titled  Advancing Health Equity and Diagnostic Technologies (GA) Development,  will focus on creating an innovative ecosystem to advance health equity throughout the southeast. This project, which includes Georgia Tech, Emory University, Morehouse School of Medicine, University of Georgia, and the Center for Global Health Innovation, aims to bridge the gap in healthcare accessibility. TCSG’s role as the workforce partner will be instrumental in training a skilled healthcare workforce equipped to leverage these innovative technologies for the betterment of the region’s population.

The third grant, titled  Advancing Cybersecurity Technologies in the Central Savannah River Area,  solidifies Augusta Technical College’s position as the workforce partner. This initiative, being led by Augusta University, recognizes the critical need to bolster cybersecurity measures in an increasingly digitized world. Augusta Technical College will spearhead efforts to develop and implement cutting-edge cybersecurity solutions. The college’s expertise and dedication to producing highly skilled cybersecurity professionals will be pivotal in fortifying the region’s defenses against cyber threats.

Through its involvement as the workforce partner, TCSG will leverage its vast resources and expertise to support these initiatives, ensuring the availability of a highly skilled workforce that meets the evolving demands of each sector. By aligning education with industry needs, TCSG will help drive economic development, innovation, and job creation across Georgia.

To learn more about the NSF Engines Development Awards, visit their  website here.

For more information about the Technical College System of Georgia, please visit  www.TCSG.edu

Legal Experts Signal Continued Uncertainty for Life Sciences M&A

By Maria Thacker Goethe • October 22, 2025
“Evolving FTC and DOJ policies leave investors and innovators navigating a cautious M&A landscape

Georgia Life Sciences Launches New Podcast Series, Vitals, in Partnership with Cloudcast Media

October 6, 2025
Atlanta, GA — October 6 — Georgia Life Sciences today announced the launch of Vitals, a new podcast series developed in partnership with Cloudcast Media, a leader in branded podcast production. The series will spotlight the people, ideas, and innovations shaping the future of Georgia’s rapidly growing life sciences sector. Hosted by Georgia Life Sciences’ CEO, Maria Thacker Goethe, Vitals will feature in-depth conversations with scientists, entrepreneurs, investors, educators, policymakers, and patient advocates. Each episode will explore the challenges and opportunities facing Georgia’s life sciences ecosystem—spanning biopharma, medical technology, digital health, and advanced manufacturing. “Vitals gives us a powerful platform to showcase the remarkable work happening within our state,” said Maria Thacker Goethe. “By sharing these stories, we’re highlighting not only groundbreaking science but also the collaboration and talent that make Georgia such a vibrant hub for health innovation.” Cloudcast Media, known for its expertise in storytelling and high-quality podcast production, will bring industry insights and technical support to ensure the series reaches audiences across Georgia and beyond. “We’re proud to partner with Georgia Life Sciences on Vitals,” said Charles Parisi, Founder and CEO of Cloudcast. “This series will elevate the voices of innovators who are advancing science, improving patient outcomes, and building Georgia’s reputation as a global life sciences leader. We are very excited that Cloudcast Atlanta can play a role in supporting Maria and the impactful work of Georgia Life Sciences.” The first episode of Vitals launched today and is available on Apple Podcasts, Spotify, and other major streaming platforms, as well as through the Georgia Life Sciences website.

BIO Statement on Most Favored Nation Policies

October 1, 2025
September 30, 2025 WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on Most Favored Nation policies: "For too many years, Americans have subsidized the research and development necessary to bring newer and better medicines to patients around the world. As we saw with defense spending and NATO, the solution is not to weaken a strategically important American industry, but for other countries to pay their fair share. “Today’s announcement in the Oval Office highlights the problems with a drug delivery system where half of the cost of innovative medicines goes to middlemen and distributors, and where the supply chain distorts prices paid by the American people. We support a new framework that addresses the cost of medicines by simplifying the system - and making medicines directly available to patients. “But importing socialist price controls through most-favored nation policies fundamentally does not address the imbalance in international pricing for innovative medicines. MFN will not lower the out-of-pocket prices that most Americans pay for medicines. Even worse, it will jeopardize the entrepreneurial spirit and deter the capital necessary for a vibrant and essential American biotechnology industry to thrive and may cause most harm to small and midsize biotech companies, which are responsible for discovering more than half of all new treatments. “Without these biotech innovators and a free-market system, we risk slower scientific progress, decreased access to new medicines, compromised national security, fewer American jobs and perhaps most tragically, a diminished hope for those suffering with illness and disease. There are much better ways to address this problem than MFN.” ###
MORE POSTS